Clinical Trial NCT05886244
Trial
Alexion – D7414C00001 (NCT05886244)
Clinical trial ID
NCT05886244
Drug name
Eculizumab
Company:
Alexion
Drug trade name
Soliris®
Clinicaltrials.gov
Learn more
Phase of study
3
Current status
Active, not recruiting
Start
07/2023
Substance
Monoclonal antibody
Research question
Safety of eculizumab
Delivery method of drug
i.v.
Frequency
Once a week for 22 days, followed by once every two weeks
Clinical trial locations
China